TipRanks
Advertisement
Advertisement

RARE Stock Latest News

Ultragenyx call volume above normal and directionally bullish
The FlyUltragenyx call volume above normal and directionally bullish
1h ago
RARE
Ultragenyx price target raised to $18 from $16 at Evercore ISI
PremiumThe Fly
Ultragenyx price target raised to $18 from $16 at Evercore ISI
2d ago
RARE
Ultragenyx price target raised to $35 from $32 at Barclays
PremiumThe Fly
Ultragenyx price target raised to $35 from $32 at Barclays
2d ago
RARE
Ultragenyx price target raised to $20 from $18 at Morgan Stanley
PremiumThe Fly
Ultragenyx price target raised to $20 from $18 at Morgan Stanley
5d ago
RARE
Abeona Therapeutics ‘congratulated’ Ultragenyx on U.S FDA approval of UX111
PremiumThe Fly
Abeona Therapeutics ‘congratulated’ Ultragenyx on U.S FDA approval of UX111
5d ago
ABEO
RARE
Ultragenyx price target raised to $39 from $37 at Canaccord
PremiumThe FlyUltragenyx price target raised to $39 from $37 at Canaccord
5d ago
RARE
Ultragenyx price target raised to $39 from $33 at Cantor Fitzgerald
Premium
The Fly
Ultragenyx price target raised to $39 from $33 at Cantor Fitzgerald
5d ago
RARE
Ultragenyx price target raised to $32 from $31 at Citi
Premium
The Fly
Ultragenyx price target raised to $32 from $31 at Citi
5d ago
RARE
Ultragenyx: Fayuvi Approval and Stronger Balance Sheet Support Hold Rating Amid Limited Near‑Term Catalysts
PremiumRatings
Ultragenyx: Fayuvi Approval and Stronger Balance Sheet Support Hold Rating Amid Limited Near‑Term Catalysts
6d ago
RARE
Ultragenyx wins FDA approval for FAYUVI gene therapy
PremiumCompany Announcements
Ultragenyx wins FDA approval for FAYUVI gene therapy
6d ago
8K
RARE
Ultragenyx confirms FDA approval of Fayuvi
PremiumThe Fly
Ultragenyx confirms FDA approval of Fayuvi
6d ago
RARE
FDA approves Ultragenyx gene therapy for Sanfilippo syndrome type A
PremiumThe Fly
FDA approves Ultragenyx gene therapy for Sanfilippo syndrome type A
6d ago
RARE
Ultragenyx call volume above normal and directionally bullish
PremiumThe FlyUltragenyx call volume above normal and directionally bullish
7d ago
RARE
Ultragenyx treatment of GNE myopathy granted orphan designation
Premium
The Fly
Ultragenyx treatment of GNE myopathy granted orphan designation
9d ago
RARE
Private Markets: Gimlet Labs, Encoded Therapeutics secure new funding
Premium
The Fly
Private Markets: Gimlet Labs, Encoded Therapeutics secure new funding
13d ago
GS
MS
Red Cat, USA Rare Earth, uniQure, Ultragenyx, Copart Trending
PremiumWeekend Updates
Red Cat, USA Rare Earth, uniQure, Ultragenyx, Copart Trending
18d ago
CPRT
QURE
Ultragenyx price target lowered to $32 from $43 at Barclays
PremiumThe Fly
Ultragenyx price target lowered to $32 from $43 at Barclays
19d ago
RARE
Ultragenyx downgraded at Morgan Stanley after Angelman study fails
PremiumThe Fly
Ultragenyx downgraded at Morgan Stanley after Angelman study fails
20d ago
RARE
Ultragenyx downgraded to Equal Weight from Overweight at Morgan Stanley
PremiumThe Fly
Ultragenyx downgraded to Equal Weight from Overweight at Morgan Stanley
20d ago
RARE
Ultragenyx Expands Rare Muscle Pipeline With First-in-Human UX016 Trial in GNE Myopathy
PremiumCompany AnnouncementsUltragenyx Expands Rare Muscle Pipeline With First-in-Human UX016 Trial in GNE Myopathy
20d ago
RARE
Ultragenyx falls -44.0%
Premium
The Fly
Ultragenyx falls -44.0%
20d ago
RARE
Midday Fly By: Nvidia to acquire Hugging Face, Broadcom reports Q3 beat
Premium
The Fly
Midday Fly By: Nvidia to acquire Hugging Face, Broadcom reports Q3 beat
20d ago
BA
LE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >